Cognition and Affect After Stroke: a Prospective Evaluation of Risks (CASPER)
Sponsor: Maastricht University Medical Center
This observational or N/A phase trial investigates Post-stroke Apathy and Post-stroke Dementia and is currently completed. Maastricht University Medical Center leads this study, which shows 13 recorded versions since 2013 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Dec 2021 — Sep 2022 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2020 — Nov 2020 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Jun 2020 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Aug 2017 — Oct 2017 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Maastricht University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .